Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The ...

Now the MSSP has had success — it saved more than $2.1 billion in 2023, the largest savings in its history — but it’s just ...

The FTC sent warning letters to 25 health plan marketers over potentially deceptive marketing practices, following its ...

Flagship Pioneering unveiled Etcelera, a new startup formed by combining three of the firm’s portfolio companies. Etcelera's ...

Documentation tools have value. They solve a visible pain point well. But solving a visible pain point is not the same as ...

Midstream's Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and ...

Setara Biosciences’ lead program is a potential treatment for the rare neuromuscular disorder Charcot-Marie-Tooth disease ...

Servier’s sevasemten came from the acquisition of the muscular dystrophy assets of Edgewise Therapeutics. While the small ...

Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical ...

For all the pink ribbons we see, women with breast cancer are abandoning one of the most effective treatments they have ...

Growing use of wearable technologies and the data they produce was discussed by a panel at the MedCity News INVEST Digital Health Conference in Dallas.

The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed ...